Chines Journal of Vector Biology and Control

• muci • Previous Articles     Next Articles

Evaluation on the Middle-Term Epidemiological Efficacy of Type ⅠInactivated Vaccine against HFRS in Anhui Province

Luo Zhao-Zhuang; Liu Hong; Wang Yi-yin; et al   

  1. Anhui Provincial health and Anti-Epidemic Station, Hefei
  • Online:1997-10-20 Published:1997-10-20

安徽省肾综合征出血热Ⅰ型灭活疫苗中期流行病学效果考核

罗兆庄1; 刘红1; 王以银1; 任次早1; 宋明宇2; 吴柄权3; 韩远荣4   

  1. 1安徽省卫生防疫站; 2霍邱县卫生防疫站; 3颖上县卫生防疫站; 4六安市卫生防疫站

Abstract: From October 1994 2 years' observation op the population innoculated with tyPe Ⅰinactivated vaccine (prepared from tissue culture of Mongolian gerbils kidney supplied by Institute of Biological Products, shanghai) showed that there was 1 case in the innoculated group, the morbidity rate was 9.27/100 000, 17 cases in the control group, the morbidity rate was 16.198/ 100 000 and the protection rate was 94.28%.The results indicated that the middle-term protection efficacy of the vaccine be sound.The case in the innoculated group was a patient of light-tyPe spoptom.Before epidemic peak (in October 1996) and after epidemic peak (in March 1997), 4 of the innoculated population had seroconversion of immunofluorescent antibody by IFA, but they had no clinical symptom.These showed that the vaccine didn't cause antibody dependent immunization enhancement.

摘要: 观察沙鼠肾细胞Ⅰ型灭活疫苗的中期流行病学效果。方法:采用间接免疫荧光抗体法(IFA)、微量细胞变性中和试验(MCPENT),分别检测荧光抗体及中和抗体;调查接种组与对照组人群发病情况。结果:自1994年10月以来的两年中,接种组发病1例(轻型),发病率为9.27/10万;对照组发病问例,发病率为161.98/10万,保护率为94.28%。流行高峰前(1996年10月)、后(1997年3月)新出现荧光抗体阳性4人,均无任何临床表现。结论:该疫苗有良好的中期防病效果;接种人群不存在免疫增强现象。

关键词: 肾综合征出血热, 灭活疫苗, 流行病学效果, 免疫增强